Literature DB >> 19183342

Array comparative genomic hybridization in retinoma and retinoblastoma tissues.

Katia Sampieri1, Mariangela Amenduni, Filomena Tiziana Papa, Eleni Katzaki, Maria Antonietta Mencarelli, Annabella Marozza, Maria Carmela Epistolato, Paolo Toti, Stefano Lazzi, Mirella Bruttini, Roberta De Filippis, Sonia De Francesco, Ilaria Longo, Ilaria Meloni, Francesca Mari, Antonio Acquaviva, Theodora Hadjistilianou, Alessandra Renieri, Francesca Ariani.   

Abstract

In retinoblastoma, two RB1 mutations are necessary for tumor development. Recurrent genomic rearrangements may represent subsequent events required for retinoblastoma progression. Array-comparative genomic hybridization was carried out in 18 eye samples, 10 from bilateral and eight from unilateral retinoblastoma patients. Two unilateral cases also showed areas of retinoma. The most frequent imbalance in retinoblastomas was 6p gain (40%), followed by gains at 1q12-q25.3, 2p24.3-p24.2, 9q22.2, and 9q33.1 and losses at 11q24.3, 13q13.2-q22.3, and 16q12.1-q21. Bilateral cases showed a lower number of imbalances than unilateral cases (P = 0.002). Unilateral cases were divided into low-level (< or = 4) and high-level (> or = 7) chromosomal instability groups. The first group presented with younger age at diagnosis (mean 511 days) compared with the second group (mean 1606 days). In one retinoma case ophthalmoscopically diagnosed as a benign lesion no rearrangements were detected, whereas the adjacent retinoblastoma displayed seven aberrations. The other retinoma case identified by retrospective histopathological examination shared three rearrangements with the adjacent retinoblastoma. Two other gene-free rearrangements were retinoma specific. One rearrangement, dup5p, was retinoblastoma specific and included the SKP2 gene. Genomic profiling indicated that the first retinoma was a pretumoral lesion, whereas the other represents a subclone of cells bearing 'benign' rearrangements overwhelmed by another subclone presenting aberrations with higher 'oncogenic' potential. In summary, the present study shows that bilateral and unilateral retinoblastoma have different chromosomal instability that correlates with the age of tumor onset in unilateral cases. This is the first report of genomic profiling in retinoma tissue, shedding light on the different nature of lesions named 'retinoma'.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183342     DOI: 10.1111/j.1349-7006.2008.01070.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  14 in total

1.  Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA.

Authors:  Gabriella Livide; Maria Carmela Epistolato; Mariangela Amenduni; Vittoria Disciglio; Annabella Marozza; Maria Antonietta Mencarelli; Paolo Toti; Stefano Lazzi; Theodora Hadjistilianou; Sonia De Francesco; Alfonso D'Ambrosio; Alessandra Renieri; Francesca Ariani
Journal:  Pathol Oncol Res       Date:  2012-01-26       Impact factor: 3.201

2.  Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism.

Authors:  Sara Amitrano; Annabella Marozza; Serena Somma; Valentina Imperatore; Theodora Hadjistilianou; Sonia De Francesco; Paolo Toti; Daniela Galimberti; Ilaria Meloni; Francesco Cetta; Pietro Piu; Chiara Di Marco; Laura Dosa; Caterina Lo Rizzo; Giulia Carignani; Maria Antonietta Mencarelli; Francesca Mari; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

Review 3.  Histopathology and molecular pathology of pediatric pineal parenchymal tumors.

Authors:  Alexandre Vasiljevic
Journal:  Childs Nerv Syst       Date:  2022-08-16       Impact factor: 1.532

Review 4.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

5.  Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma.

Authors:  Ursula Winter; Daiana Ganiewich; Daniela Ottaviani; Santiago Zugbi; Rosario Aschero; Juan Martin Sendoya; Eduardo G Cafferata; Marcela Mena; Mariana Sgroi; Claudia Sampor; Fabiana Lubieniecki; Adriana Fandiño; Martin C Abba; François Doz; Osvaldo Podhjacer; Angel Montero Carcaboso; Eric Letouzé; François Radvanyi; Guillermo L Chantada; Andrea S Llera; Paula Schaiquevich
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

6.  Variability in retinoblastoma genome stability is driven by age and not heritability.

Authors:  Ashley Polski; Liya Xu; Rishvanth K Prabakar; Xiaowu Gai; Jonathan W Kim; Rachana Shah; Rima Jubran; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Genes Chromosomes Cancer       Date:  2020-06-09       Impact factor: 5.006

7.  Investigation of modifier genes within copy number variations in Rett syndrome.

Authors:  Rosangela Artuso; Filomena T Papa; Elisa Grillo; Mafalda Mucciolo; Dag H Yasui; Keith W Dunaway; Vittoria Disciglio; Maria A Mencarelli; Marzia Pollazzon; Michele Zappella; Giuseppe Hayek; Francesca Mari; Alessandra Renieri; Janine M Lasalle; Francesca Ariani
Journal:  J Hum Genet       Date:  2011-05-19       Impact factor: 3.172

8.  Retinoblastoma: Recent trends A mini review based on published literature.

Authors:  Vikas Khetan; Aditi Gupta; Lingam Gopal
Journal:  Oman J Ophthalmol       Date:  2011-09

9.  Comprehensive Somatic Copy Number Analysis Using Aqueous Humor Liquid Biopsy for Retinoblastoma.

Authors:  Mary E Kim; Ashley Polski; Liya Xu; Rishvanth K Prabakar; Chen-Ching Peng; Mark W Reid; Rachana Shah; Peter Kuhn; David Cobrinik; James Hicks; Jesse L Berry
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

Review 10.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.